Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Racial differences in tamoxifen metabolism.

Flaws1, Lim, Luo

  • 1Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, MD, USA

Annals of Epidemiology
|October 6, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case of Dropsy.

The Medical and physical journal·2018
Same author

Actin rearrangements accompanying Aeromonas hydrophila entry into cultured fish cells.

Journal of fish diseases·2018
Same author

HAL1 mediate salt adaptation in Arabidopsis thaliana.

Cell research·2001
Same author

pH-dependent toxicity of copper and uranium to a tropical freshwater alga (Chlorella sp.).

Aquatic toxicology (Amsterdam, Netherlands)·2001
Same author

Cooling System Permits Effective Transcutaneous Ultrasound Clot Lysis In Vivo Without Skin Damage.

Journal of thrombosis and thrombolysis·2001
Same author

Caudal ropivacaine in infants: population pharmacokinetics and plasma concentrations

Paediatric anaesthesia·2000
Same journal

Contribution of lifestyle factors to sex differences in educational inequalities in life expectancy in selected European countries.

Annals of epidemiology·2026
Same journal

What remains quantitative in quantitative intersectionality?

Annals of epidemiology·2026
Same journal

Revisiting the role of interaction effects in quantitative intersectionality research.

Annals of epidemiology·2026
Same journal

GLP-1 receptor agonist medications for weight loss: Sociodemographic patterns of awareness, use, and access in a U.S. national cohort.

Annals of epidemiology·2026
Same journal

Even low levels of physical activity are associated with lower all-cause mortality: A cohort study of 594,000 US adults.

Annals of epidemiology·2026
Same journal

Comment on "Distinct differences between COVID-19 vaccine refusers and vaccine hesitant in the United States: Results from a population-based survey and latent class analysis".

Annals of epidemiology·2026
See all related articles

Black women metabolize tamoxifen differently than white women, leading to higher levels of a less effective metabolite (N-desmethyltamoxifen). This may explain racial disparities in tamoxifen treatment outcomes for breast cancer patients.

Area of Science:

  • Pharmacogenomics
  • Oncology
  • Drug Metabolism

Background:

  • Racial disparities exist in tamoxifen's risk/benefit ratio for breast cancer treatment.
  • Drug metabolism differences across races may contribute to varying pharmaceutical efficacy and risks.
  • Tamoxifen metabolism is a key factor in its effectiveness for breast cancer.

Purpose of the Study:

  • To investigate if racial differences in tamoxifen metabolism contribute to observed disparities in treatment outcomes between black and white women.
  • To test the hypothesis that altered tamoxifen metabolism in black women impacts its risk/benefit profile.

Main Methods:

  • A pilot study involving 6 white and 4 black breast cancer patients undergoing tamoxifen therapy.
  • Measurement of tamoxifen metabolites in patient blood samples using high-performance liquid chromatography.

Related Experiment Videos

  • Comparison of serum tamoxifen and N-desmethyltamoxifen (N-DMT) levels between racial groups.

    • Main Results:

    • Black women exhibited significantly higher serum levels of the tamoxifen metabolite N-desmethyltamoxifen (N-DMT) compared to white women (0.585 µg/ml vs 0.199 µg/ml, p < 0.05).
    • No significant differences were observed in the overall serum levels of tamoxifen between black and white patients (0.809 vs 0.699, p > 0.1).

    Conclusions:

    • Black breast cancer patients appear to metabolize tamoxifen to N-DMT more readily or retain higher N-DMT levels than white patients.
    • N-desmethyltamoxifen (N-DMT) is considered less effective for breast cancer treatment and may promote cancer cell proliferation.
    • These findings suggest that altered tamoxifen metabolism to N-DMT in black women could underlie their higher tamoxifen risk/benefit ratio, warranting further investigation in larger cohorts.